UroGen Pharma (URGN) Stock Chart & Stock Price History $11.93 -0.27 (-2.21%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends UroGen Pharma Stock Price Performance5 Day Performance-2.69%1 Month Performance-6.06%3 Month Performance-22.03%6 Month Performance-16.57%Year-To-Date Performance-20.47%1 Year Performance+3.11% Receive URGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW URGN Stock Chart for Tuesday, November, 5, 2024 URGN Chart by TradingView UroGen Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$12.20$11.93-2.21%$12.33$11.84345,357 shs$279.76 million11/01/2024$12.26$12.20-0.49%$12.66$12.07603,192 shs$286.14 million10/31/2024$13.02$12.26-5.84%$13.13$12.24394,853 shs$287.55 million10/30/2024$12.25$13.02+6.29%$13.33$12.16943,436 shs$305.37 million10/29/2024$12.15$12.25+0.82%$12.45$12.03423,399 shs$287.31 million10/28/2024$12.10$12.15+0.41%$12.54$12.15246,017 shs$284.97 million Get the Latest News and Ratings for URGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$12.10$12.10$12.38$11.89448,852 shs$283.79 million10/24/2024$12.13$12.10-0.25%$12.41$11.92401,473 shs$283.79 million10/23/2024$12.47$12.13-2.73%$12.59$12.00421,148 shs$284.45 million10/22/2024$12.52$12.47-0.40%$12.52$12.28378,955 shs$292.42 million10/21/2024$12.73$12.52-1.65%$12.82$12.42543,330 shs$293.59 million10/18/2024$12.84$12.73-0.86%$13.00$12.43540,554 shs$298.57 million10/17/2024$12.60$12.84+1.90%$13.12$12.22712,880 shs$301.15 million10/16/2024$12.26$12.60+2.77%$13.54$12.152.03 million shs$295.47 million10/15/2024$12.26$12.26$12.31$11.84760,933 shs$287.55 million10/14/2024$12.60$12.26-2.70%$13.64$12.18982,954 shs$287.55 million10/11/2024$11.91$12.60+5.79%$12.63$11.61735,342 shs$295.47 million10/10/2024$11.89$11.91+0.17%$12.15$11.401.28 million shs$279.34 million10/09/2024$13.11$11.89-9.31%$13.00$11.302.38 million shs$278.87 million10/08/2024$12.42$13.11+5.56%$13.25$12.33734,799 shs$307.43 million10/07/2024$12.70$12.42-2.20%$12.74$12.22634,104 shs$291.30 million10/04/2024$12.38$12.70+2.58%$12.89$12.43254,463 shs$297.82 million10/03/2024$12.58$12.38-1.59%$12.61$12.27203,115 shs$290.36 million10/02/2024$12.48$12.58+0.80%$12.80$12.30205,319 shs$295.05 million10/01/2024$12.70$12.48-1.73%$12.79$12.22922,513 shs$292.71 million09/30/2024$12.90$12.70-1.55%$13.08$12.60331,163 shs$297.82 million09/27/2024$12.75$12.90+1.18%$13.08$12.61377,008 shs$302.56 million09/26/2024$12.86$12.75-0.86%$13.31$12.70399,753 shs$299.04 million09/25/2024$13.06$12.86-1.53%$13.15$12.71349,141 shs$301.57 million09/24/2024$12.97$13.06+0.69%$13.27$12.77346,459 shs$306.31 million09/23/2024$13.54$12.97-4.21%$13.66$12.82355,779 shs$304.20 million09/20/2024$13.85$13.54-2.24%$14.00$13.341.22 million shs$317.51 million09/19/2024$13.10$13.85+5.73%$14.57$13.24986,293 shs$324.78 million09/18/2024$12.84$13.10+2.02%$13.41$12.751.20 million shs$307.20 million09/17/2024$13.20$12.84-2.73%$13.41$12.81610,619 shs$301.15 million09/16/2024$13.12$13.20+0.61%$13.96$13.18480,739 shs$309.54 million09/13/2024$13.05$13.12+0.54%$13.64$13.00421,129 shs$307.66 million09/12/2024$13.81$13.05-5.50%$13.90$12.83967,134 shs$306.08 million09/11/2024$13.42$13.81+2.91%$13.82$13.34222,498 shs$323.84 million09/10/2024$13.35$13.42+0.52%$13.51$13.00214,736 shs$314.70 millionMarket "Famine" Coming (Ad)Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicted the 2020 crash a month before it happened...For a limited time, he's revealing his latest forecast here.09/09/2024$13.23$13.35+0.91%$13.68$13.08281,168 shs$313.06 million09/06/2024$13.73$13.23-3.64%$13.76$13.14562,465 shs$310.24 million09/05/2024$13.97$13.73-1.72%$13.99$13.43405,413 shs$322.02 million09/04/2024$13.56$13.97+3.02%$14.13$13.40242,748 shs$327.65 million09/03/2024$13.91$13.56-2.52%$14.27$13.43355,860 shs$318.04 million09/02/2024$13.91$13.91$14.38$13.69924,800 shs$326.19 million08/30/2024$14.00$13.91-0.64%$14.38$13.69924,667 shs$326.25 million08/29/2024$14.08$14.00-0.57%$14.29$13.90403,056 shs$328.30 million08/28/2024$14.27$14.08-1.33%$14.44$14.03355,971 shs$330.23 million08/27/2024$14.29$14.27-0.14%$14.38$13.95419,218 shs$334.69 million08/26/2024$14.16$14.29+0.92%$14.50$14.15411,272 shs$335.16 million08/23/2024$14.45$14.16-2.01%$15.02$14.001.05 million shs$332.11 million08/22/2024$14.87$14.45-2.82%$15.87$14.401.25 million shs$338.91 million08/21/2024$15.00$14.87-0.87%$15.39$14.70305,080 shs$348.76 million08/20/2024$14.72$15.00+1.90%$15.37$14.61490,322 shs$351.75 million08/19/2024$14.80$14.72-0.54%$14.93$14.41421,218 shs$345.24 million08/16/2024$15.49$14.80-4.45%$15.63$14.75359,197 shs$347.12 million08/15/2024$14.94$15.49+3.72%$16.19$15.14462,430 shs$363.24 million08/14/2024$14.96$14.94-0.17%$15.36$14.47510,978 shs$350.23 million08/13/2024$14.51$14.96+3.10%$15.77$14.02869,308 shs$350.81 million08/12/2024$14.66$14.51-1.02%$15.02$14.22326,030 shs$340.26 million08/09/2024$14.99$14.66-2.20%$15.23$14.52251,077 shs$343.78 million08/08/2024$14.47$14.99+3.59%$15.01$14.40367,475 shs$351.52 million08/07/2024$15.16$14.47-4.55%$15.32$14.42275,744 shs$339.38 million08/06/2024$15.30$15.16-0.92%$15.73$15.01235,812 shs$355.50 million08/05/2024$15.68$15.30-2.42%$15.46$14.59392,005 shs$358.79 million Related Companies Akebia Therapeutics Stock Chart Puma Biotechnology Stock Chart RAPT Therapeutics Stock Chart Marinus Pharmaceuticals Stock Chart Cogent Biosciences Stock Chart Disc Medicine Stock Chart Immatics Stock Chart Bicycle Therapeutics Stock Chart ArriVent BioPharma Stock Chart Evolus Stock Chart Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:URGN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UroGen Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share UroGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.